For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.

22nd Aug 11

Re-examination Documents Submitted for EU Bronchitol Marketing Application

Pharmaxis today announced that it had submitted detailed grounds for re-examination of its Bronchitol EU marketing application for cystic fibrosis to the Committee for Medicinal Products for Human Use.The documents have been lodged following the formal request for re-examination submitted last month and subsequent dialogue between the Company and the new Rapporteurs appointed to lead the process.


Read full media release - pdf